Duncan Stearns
Overview
Explore the profile of Duncan Stearns including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
24
Citations
1105
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gajjar A, Mahajan A, Bale T, Bowers D, Canan L, Chi S, et al.
J Natl Compr Canc Netw
. 2025 Mar;
23(3):113-130.
PMID: 40073837
The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Pediatric Central Nervous System Cancers provide multidisciplinary diagnostic workup, staging, and treatment recommendations for diffuse high-grade gliomas and medulloblastomas in...
2.
Ercan A, Aronson M, Fernandez N, Chang Y, Levine A, Liu Z, et al.
Lancet Oncol
. 2024 Mar;
25(5):668-682.
PMID: 38552658
Background: Constitutional mismatch repair deficiency (CMMRD) syndrome is a rare and aggressive cancer predisposition syndrome. Because a scarcity of data on this condition contributes to management challenges and poor outcomes,...
3.
Rivers Z, Hyde B, Ronski K, Stearns D, Toll S, Ritt K, et al.
Clin Ther
. 2023 Oct;
45(11):1148-1150.
PMID: 37783645
The Research to Accelerate Cures and Equity (RACE) for Children Act mandates that newly developed targeted oncology drugs be tested in children when molecular targets are relevant to pediatric cancers....
4.
Gajjar A, Mahajan A, Abdelbaki M, Anderson C, Antony R, Bale T, et al.
J Natl Compr Canc Netw
. 2022 Dec;
20(12):1339-1362.
PMID: 36509072
Central nervous system (CNS) cancers account for approximately one quarter of all pediatric tumors and are the leading cause of cancer-related death in children. More than 4,000 brain and CNS...
5.
Durno C, Ercan A, Bianchi V, Edwards M, Aronson M, Galati M, et al.
J Clin Oncol
. 2021 May;
39(25):2779-2790.
PMID: 33945292
Purpose: Constitutional mismatch repair deficiency syndrome (CMMRD) is a lethal cancer predisposition syndrome characterized by early-onset synchronous and metachronous multiorgan tumors. We designed a surveillance protocol for early tumor detection...
6.
De Sa H, Pearl J, Hibbs A, Pereda M, Suzuki I, Curtis S, et al.
Adv Neonatal Care
. 2021 Jan;
22(1):42-46.
PMID: 33417327
Background: Ewing sarcoma (EWS) is an aggressive soft-tissue and bone malignancy. Congenital EWS is extremely rare, and its presenting features can be unique from that of EWS occurring in older...
7.
Gestrich C, Jajosky A, Elliott R, Stearns D, Sadri N, Cohen M, et al.
Am J Clin Pathol
. 2020 Nov;
155(4):606-614.
PMID: 33210143
Objectives: Although glioblastoma (GBM) is rare in the pediatric population, it is the most common cause of death among children with central nervous system neoplasms. Recent molecular profiling of these...
8.
Dodgshun A, Fukuoka K, Edwards M, Bianchi V, Das A, Sexton-Oates A, et al.
Acta Neuropathol
. 2020 Sep;
140(5):765-776.
PMID: 32895736
Replication repair deficiency (RRD) leading to hypermutation is an important driving mechanism of high-grade glioma (HGG) occurring predominantly in the context of germline mutations in RRD-associated genes. Although HGG presents...
9.
de Blank P, Badve C, Gold D, Stearns D, Sunshine J, Dastmalchian S, et al.
Pediatr Neurosurg
. 2019 Aug;
54(5):310-318.
PMID: 31416081
Object: Magnetic resonance fingerprinting (MRF) allows rapid, simultaneous mapping of T1 and T2 relaxation times and may be an important diagnostic tool to measure tissue characteristics in pediatric brain tumors....
10.
Natsumeda M, Liu Y, Nakata S, Miyahara H, Hanaford A, Ahsan S, et al.
Neuropathology
. 2019 Jan;
39(2):71-77.
PMID: 30632221
MYC amplification is common in Group 3 medulloblastoma and is associated with poor survival. Group 3 and Group 4 medulloblastomas are also known to have elevated levels of histone H3-lysine...